Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Compounders Gain Flexibility In Quality Standards Due To PPE Shortages

Executive Summary

The US FDA will allow pharmacy compounders to use non-sterile masks and gloves in cleanrooms, but risk strategies must be in place to ensure products are as contaminant-free as possible. Discretion responds to the current shortage of protective gear  due to the COVID-19 pandemic.

You may also be interested in...

Second EUA For Mask Decontamination Tech Goes To Steris

The US FDA has issued an emergency use authorization permitting the Steris V-PRO to be used to decontaminate masks used by medical professionals during the COVID-19 pandemic. The technology could get as many as 750,000 more clean N95 masks to medical personnel each day, the agency says.

The FDA Aims To Strike Balance On Inspecting Physicians Who Compound Drugs

Just how much will the FDA look the other way when it comes to inspecting physician compounders?

Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others

Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts